Pfizer’s Emblaveo gets EC approval for treatment of multidrug-resistant infections
Emblaveo underwent review through the EMA accelerated assessment procedure, which is employed for pharmaceutical products deemed of significant…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Apr 24
Emblaveo underwent review through the EMA accelerated assessment procedure, which is employed for pharmaceutical products deemed of significant…
23 Apr 24
Ipsen would acquire an exclusive global license to develop successful development candidates (DC), by paying up to $1.8bn…
23 Apr 24
The partnership agreement, which has the potential to earn more than $1bn for Ochre Bio, aims to discover…
23 Apr 24
The approval is for patients with BCG-unresponsive non-muscle invasive bladder cancer presenting carcinoma in situ, irrespective of papillary…
23 Apr 24
Thanks to Covid-19, self-testing has become a common practice. Throughout the next few years, experts believe that this…
23 Apr 24
Upon completion, this acquisition will expand Lilly's growing U.S. capacity to produce the latest life-changing medicines
23 Apr 24
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and…
22 Apr 24
The approval was based on results from Phase 3 ALINA study in which Alecensa lowered the risk of…
19 Apr 24
The regulator has authorised Entyvio as a maintenance drug for individuals with moderately to highly active Crohn's disease…
19 Apr 24
The pharma company is currently recruiting patients in the Phase 2 GenePHIT study to assess the safety and…